228 related articles for article (PubMed ID: 26392164)
1. Vascular endothelial growth factor (VEGF) and lovastatin suppress the inflammatory response to Plasmodium berghei infection and protect against experimental cerebral malaria.
Canavese M; Crisanti A
Pathog Glob Health; 2015 Sep; 109(6):266-74. PubMed ID: 26392164
[TBL] [Abstract][Full Text] [Related]
2. VEGF and LPS synergistically silence inflammatory response to Plasmodium berghei infection and protect against cerebral malaria.
Canavese M; Dottorini T; Crisanti A
Pathog Glob Health; 2015 Sep; 109(6):255-65. PubMed ID: 26392042
[TBL] [Abstract][Full Text] [Related]
3. Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria.
Reis PA; Estato V; da Silva TI; d'Avila JC; Siqueira LD; Assis EF; Bozza PT; Bozza FA; Tibiriça EV; Zimmerman GA; Castro-Faria-Neto HC
PLoS Pathog; 2012 Dec; 8(12):e1003099. PubMed ID: 23300448
[TBL] [Abstract][Full Text] [Related]
4. Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice.
Recuenco FC; Takano R; Chiba S; Sugi T; Takemae H; Murakoshi F; Ishiwa A; Inomata A; Horimoto T; Kobayashi Y; Horiuchi N; Kato K
Malar J; 2014 Dec; 13():487. PubMed ID: 25495520
[TBL] [Abstract][Full Text] [Related]
5. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy.
Reis PA; Comim CM; Hermani F; Silva B; Barichello T; Portella AC; Gomes FC; Sab IM; Frutuoso VS; Oliveira MF; Bozza PT; Bozza FA; Dal-Pizzol F; Zimmerman GA; Quevedo J; Castro-Faria-Neto HC
PLoS Pathog; 2010 Jun; 6(6):e1000963. PubMed ID: 20585569
[TBL] [Abstract][Full Text] [Related]
6. Neuregulin-1 attenuates mortality associated with experimental cerebral malaria.
Solomon W; Wilson NO; Anderson L; Pitts S; Patrickson J; Liu M; Ford BD; Stiles JK
J Neuroinflammation; 2014 Jan; 11():9. PubMed ID: 24433482
[TBL] [Abstract][Full Text] [Related]
7. Perillyl alcohol exhibits in vitro inhibitory activity against Plasmodium falciparum and protects against experimental cerebral malaria.
Rodriguez AAM; Carvalho LJM; Kimura EA; Katzin AM
Int J Antimicrob Agents; 2018 Mar; 51(3):370-377. PubMed ID: 28843818
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of uncomplicated Plasmodium berghei ANKA malaria on memory and anxiety-like behaviour in C57BL/6 mice.
de Sousa LP; de Almeida RF; Ribeiro-Gomes FL; de Moura Carvalho LJ; E Souza TM; de Souza DOG; Daniel-Ribeiro CT
Parasit Vectors; 2018 Mar; 11(1):191. PubMed ID: 29554958
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria.
Campos AC; Brant F; Miranda AS; Machado FS; Teixeira AL
Neuroscience; 2015 Mar; 289():166-80. PubMed ID: 25595981
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signaling 2 modulates the immune response profile and development of experimental cerebral malaria.
Brant F; Miranda AS; Esper L; Gualdrón-López M; Cisalpino D; de Souza DDG; Rachid MA; Tanowitz HB; Teixeira MM; Teixeira AL; Machado FS
Brain Behav Immun; 2016 May; 54():73-85. PubMed ID: 26765997
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of Coenzyme Q
Nyariki JN; Ochola LA; Jillani NE; Nyamweya NO; Amwayi PE; Yole DS; Azonvide L; Isaac AO
Parasitol Int; 2019 Aug; 71():106-120. PubMed ID: 30981893
[TBL] [Abstract][Full Text] [Related]
12. Terminalia albida treatment improves survival in experimental cerebral malaria through reactive oxygen species scavenging and anti-inflammatory properties.
Camara A; Haddad M; Reybier K; Traoré MS; Baldé MA; Royo J; Baldé AO; Batigne P; Haidara M; Baldé ES; Coste A; Baldé AM; Aubouy A
Malar J; 2019 Dec; 18(1):431. PubMed ID: 31852507
[TBL] [Abstract][Full Text] [Related]
13. Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators.
Schmidt KE; Kuepper JM; Schumak B; Alferink J; Hofmann A; Howland SW; Rénia L; Limmer A; Specht S; Hoerauf A
PLoS One; 2018; 13(2):e0192717. PubMed ID: 29438386
[TBL] [Abstract][Full Text] [Related]
14. Natural regulatory T cells mediate the development of cerebral malaria by modifying the pro-inflammatory response.
Wu JJ; Chen G; Liu J; Wang T; Zheng W; Cao YM
Parasitol Int; 2010 Jun; 59(2):232-41. PubMed ID: 20219695
[TBL] [Abstract][Full Text] [Related]
15. Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria.
Du Y; Chen G; Zhang X; Yu C; Cao Y; Cui L
Int Immunopharmacol; 2017 Jul; 48():219-230. PubMed ID: 28531845
[TBL] [Abstract][Full Text] [Related]
16. Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner.
Schmidt KE; Schumak B; Specht S; Dubben B; Limmer A; Hoerauf A
Microbes Infect; 2011 Sep; 13(10):828-36. PubMed ID: 21609776
[TBL] [Abstract][Full Text] [Related]
17. Regulation of endothelial cell adhesion molecule expression in an experimental model of cerebral malaria.
Bauer PR; Van Der Heyde HC; Sun G; Specian RD; Granger DN
Microcirculation; 2002 Dec; 9(6):463-70. PubMed ID: 12483543
[TBL] [Abstract][Full Text] [Related]
18. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
[TBL] [Abstract][Full Text] [Related]
19. Coenzyme Q10 exhibits anti-inflammatory and immune-modulatory thereby decelerating the occurrence of experimental cerebral malaria.
Nyariki JN; Kimani NM; Kibet PS; Kinuthia GK; Isaac AO
Mol Biochem Parasitol; 2023 Sep; 255():111579. PubMed ID: 37385350
[TBL] [Abstract][Full Text] [Related]
20. Glutathione peroxidase contributes with heme oxygenase-1 to redox balance in mouse brain during the course of cerebral malaria.
Linares M; Marín-García P; Martínez-Chacón G; Pérez-Benavente S; Puyet A; Diez A; Bautista JM
Biochim Biophys Acta; 2013 Dec; 1832(12):2009-18. PubMed ID: 23872112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
